School of Life Science and Biopharmaceutics, Shenyang Pharmaceutical University, No. 103, Wen hua Road, Shenyang 110016, China.
Beijing Key Laboratory of Drug Targets Identification and Drug Screening, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 2, Nan wei Road, Beijing 100050, China.
Biomed Res Int. 2019 Jul 10;2019:6847685. doi: 10.1155/2019/6847685. eCollection 2019.
Xiaoxuming decoction (XXMD), a classic traditional Chinese medicine (TCM) prescription, has been used as a therapeutic in the treatment of stroke in clinical practice for over 1200 years. However, the pharmacological mechanisms of XXMD have not yet been elucidated. The purpose of this study was to develop neuroprotective models for identifying neuroprotective compounds in XXMD against hypoxia-induced and HO-induced brain cell damage. In this study, a phenotype-based classification method was designed by machine learning to identify neuroprotective compounds and to clarify the compatibility of XXMD components. Four different single classifiers (AB, kNN, CT, and RF) and molecular fingerprint descriptors were used to construct stacked naïve Bayesian models. Among them, the RF algorithm had a better performance with an average MCC value of 0.725±0.014 and 0.774±0.042 from 5-fold cross-validation and test set, respectively. The probability values calculated by four models were then integrated into a stacked Bayesian model. In total, two optimal models, s-NB-1-LPFP6 and s-NB-2-LPFP6, were obtained. The two validated optimal models revealed Matthews correlation coefficients (MCC) of 0.968 and 0.993 for 5-fold cross-validation and of 0.874 and 0.959 for the test set, respectively. Furthermore, the two models were used for virtual screening experiments to identify neuroprotective compounds in XXMD. Ten representative compounds with potential therapeutic effects against the two phenotypes were selected for further cell-based assays. Among the selected compounds, two compounds significantly inhibited HO-induced and NaSO-induced neurotoxicity simultaneously. Together, our findings suggested that machine learning algorithms such as combination Bayesian models were feasible to predict neuroprotective compounds and to preliminarily demonstrate the pharmacological mechanisms of TCM.
消眩明目的中药方剂,用于临床治疗中风已有 1200 多年的历史。但是,其药物作用机制尚不清楚。本研究旨在建立神经保护模型,用于识别治疗缺血缺氧性和双氧水诱导的脑细胞损伤的神经保护化合物。本研究采用基于表型的分类方法,通过机器学习识别神经保护化合物,并阐明消眩明目的配方成分的协同作用。使用四种不同的单分类器(AB、kNN、CT 和 RF)和分子指纹描述符构建堆叠朴素贝叶斯模型。其中,RF 算法的性能较好,其 5 折交叉验证和测试集的平均 MCC 值分别为 0.725±0.014 和 0.774±0.042。然后,将四个模型计算出的概率值整合到一个堆叠的贝叶斯模型中。最终得到了两个最佳模型 s-NB-1-LPFP6 和 s-NB-2-LPFP6。这两个经过验证的最优模型在 5 折交叉验证中的 MCC 值分别为 0.968 和 0.993,在测试集的 MCC 值分别为 0.874 和 0.959。此外,这两个模型还用于虚拟筛选实验,以识别消眩明目的神经保护化合物。选择了十种具有潜在治疗作用的代表性化合物,用于进一步的细胞实验。在选定的化合物中,有两种化合物能同时显著抑制双氧水诱导和亚硫酸钠诱导的神经毒性。总之,我们的研究结果表明,组合贝叶斯模型等机器学习算法可用于预测神经保护化合物,并初步验证中药的药物作用机制。